TransMedics Group, Inc. - Common Stock (TMDX)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
33,940,151
Total 13F shares
19,228,051
Share change
+398,799
Total reported value
$636,265,034
Put/Call ratio
54%
Price per share
$33.09
Number of holders
116
Value change
+$13,188,365
Number of buys
63
Number of sells
46

Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2021

As of 30 Sep 2021, TransMedics Group, Inc. - Common Stock (TMDX) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,228,051 shares. The largest 10 holders included FMR LLC, BlackRock Inc., MACQUARIE GROUP LTD, CREDIT SUISSE AG/, Sandhill Capital Partners LLC, VANGUARD GROUP INC, KPCB XIII Associates, LLC, STATE STREET CORP, Bellevue Group AG, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 116 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.